Tempus AI, Inc. Class A Common Stock (TEM)vs10X Genomics Inc (TXG)
TEM
Tempus AI, Inc. Class A Common Stock
$46.76
-4.24%
HEALTHCARE · Cap: $8.73B
TXG
10X Genomics Inc
$20.91
+5.55%
HEALTHCARE · Cap: $2.53B
Smart Verdict
WallStSmart Research — data-driven comparison
Tempus AI, Inc. Class A Common Stock generates 98% more annual revenue ($1.27B vs $642.82M). TXG leads profitability with a -6.8% profit margin vs -19.3%. TXG earns a higher WallStSmart Score of 32/100 (F).
TEM
Avoid31
out of 100
Grade: F
TXG
Avoid32
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 83.0% year-over-year
No standout strengths identified
Areas to Watch
Trading at 16.9x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
0.6% revenue growth
0.0% earnings growth
ROE of -5.8% — below average capital efficiency
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bull Case : TXG
TXG has a balanced fundamental profile.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Bear Case : TXG
The primary concerns for TXG are Revenue Growth, EPS Growth, Return on Equity.
Key Dynamics to Monitor
TEM profiles as a hypergrowth stock while TXG is a turnaround play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
TXG generates stronger free cash flow (39M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TXG scores higher overall (32/100 vs 31/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →10X Genomics Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?